Migraine prevention injection in patients with unsuccessful prior preventive treatments
The objective of the trial is to assess the efficacy of the study drug for prevention of migraine at different doses compared to placebo in patients who have failed multiple preventive treatments.
Inclusion Criteria:
- In order to be eligible, you have to have at least 4 migraine days per month and in the past 10 years have failed 2 to 4 different migraine preventive medications.
For more information please contact Andrea Bryan 716-250-2017, abryan@dentinstitute.com